Coronavirus infection after blood stem cell transplantation

Coronavirus infection after blood stem cell transplantation

Background. In March 2020, oncohematologists faced the problem of severe COVID-19 coronavirus infection in patients after a high-dose chemotherapy and autologous or allogeneic bone marrow transplantation. This required a review of issues related to the selection of patients for blood stem cell trans...

Full description

Saved in:

Bibliographic Details
Main Authors:	E. Yu. Grishina, E. N. Misyurina, E. I. Zhelnova, E. A. Baryakh, K. V. Yatskov, A. B. Makeshova, E. A. Karimova, E. N. Zotina, D. E. Gagloeva, V. N. Yakimets, M. A. Mingalimov, T. N. Tolstykh, Yu. Yu. Polyakov, T. S. Chudnova, O. L. Kochneva, L. T. Shimanovskaya
Format:	Article
Language:	Russian
Published:	ABV-press 2024-01-01
Series:	Онкогематология
Subjects:	stem cell transplantation covid-19 multiple myeloma viral infections lymphoproliferative disease
Online Access:	https://oncohematology.abvpress.ru/ongm/article/view/888
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Basic therapeutic approaches to the management of hematology/oncology patients with new coronavirus infection (COVID-19)
by: E. N. Misyurina, et al.
Published: (2024-01-01)

Clinical features and treatment strategy for patients with multiple myeloma during the COVID-19 pandemic
by: V. N. Yakimets, et al.
Published: (2024-01-01)

Treatment experience of coronavirus infection associated with SARS-CoV-2 in patients with acute myeloid leukemia in the older age group
by: L. T. Shimanovskaya, et al.
Published: (2024-01-01)

Prognostic model and risk factors for hospital mortality in patients with diffuse large B-cell lymphoma associated with coronavirus infection: a single-center cohort study
by: Yu. Yu. Polyakov, et al.
Published: (2024-01-01)

COVID-19 in patients with acute lymphoblastic leukemia
by: T. S. Chudnova, et al.
Published: (2024-09-01)

COVID-19 in patients with acute leukemia: 3 years' experience of pandemic
by: T. S. Chudnova, et al.
Published: (2024-01-01)

Treatment features of adult patients with acute myeloid leukemia during the COVID-19 pandemic
by: D. E. Gagloeva, et al.
Published: (2024-01-01)

Chronic lymphocytic leukemia in combination with COVID-19: clinical features and unfavorable prognosis factors
by: O. L. Kochneva, et al.
Published: (2024-01-01)

Treatment of elderly patients with acute myeloid leukemia: personal experience
by: L. T. Shimanovskaya, et al.
Published: (2024-12-01)

Sinonasal diffuse large B-cell lymphoma: own clinical observation and literature review
by: M. A. Mingalimov, et al.
Published: (2024-04-01)

Chemotherapy of hematological malignancies in patients with COVID-19
by: T. S. Chudnova, et al.
Published: (2022-04-01)

Treatment efficiency in patients with acute myeloid leukemia from 2019 to 2023 according to the Moscow Cancer Registry
by: T. N. Tolstykh, et al.
Published: (2024-09-01)

Persistence of a new coronavirus infection in a patient with primary central nervous system large B-cell lymphoma with assessment of the humoral immune response against SARS-CoV-2
by: Yu. Yu. Polyakov, et al.
Published: (2024-04-01)

Personalized genotype-directed antitumor therapy for newly diagnosed diffuse large B-cell lymphoma: efficacy and toxicity of the R-CHOP-X protocol in a single-center, non-randomized, prospective clinical trial (first results)
by: M. A. Mingalimov, et al.
Published: (2024-12-01)

Issue of predicting the risk of thromboembolic complications in patients with lymphoproliferative diseases
by: S. V. Ignatiev, et al.
Published: (2022-04-01)

Lymphoproliferative diseases in primary Sjogren's syndrome
by: V. i. Vasiljev, et al.
Published: (2022-11-01)

Nivolumab-containing therapy in patients with newly diagnosed classical Hodgkin lymphoma: own clinical observations and literature review
by: D. D. Ivanova, et al.
Published: (2024-12-01)

Prevalence and Significance of Incidental PET/CT Findings of Cancer Detected in Patients Evaluated for Their Primary Hematologic Malignancy: A Systematic Review
by: Jessie Luo, et al.
Published: (2024-11-01)

Study of proinflammatory markers, galectin-3 level, lipid metabolism parameters, cardiovascular status and their relationship in patients with lymphomas before antitumor therapy
by: I. Ya. Sokolova, et al.
Published: (2025-03-01)

Epstein–Barr virus infection in patients after hematopoietic stem cells transplantation
by: D. N. Balashov, et al.
Published: (2022-11-01)

Prognostic Value of the PRAME Gene Expression in T-Cell Lymphoproliferative Disorders
by: EA Penskaya, et al.
Published: (2018-12-01)

Complete regression of generalized plasmacytoma of lymph nodes in a liver transplant recipient during the conversion of immunosuppressive therapy from tacrolimus to everolimus
by: V. E. Syutkin, et al.
Published: (2021-09-01)

Pathogenesis and therapy of anemia in oncohemathology patients with recombinant erythropoietin agents (review)
by: N. A. Romanenko
Published: (2014-07-01)

Primary central nervous system post-transplant lymphoproliferative Disorder in a lung transplant recipient despite reduction of immunosuppression
by: K Afshar, et al.
Published: (2025-02-01)

EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS
by: Pietro Tralongo, et al.
Published: (2024-04-01)

Patogenetic correction of anemia with erythropoiesis-stimulating agents in lymphoproliferative disorders (literature review)
by: N. A. Romanenko, et al.
Published: (2014-07-01)

Chronic lymphoproliferative diseases: survival in cohort study of 310 patients (single-center study results and literature data)
by: V. P. Pop, et al.
Published: (2015-01-01)

Left Atrium Involvement in Lymphoma Patients: Single Center Observational Study
by: E. Yu. Salakheeva, et al.
Published: (2022-09-01)

Characteristics of clinical, laboratory, and immunological manifestations in patients with anticentromere antibody-associated Sjögren's disease
by: B. D. Chaltsev, et al.
Published: (2020-11-01)

Pathogenetic and substitution correction of anemia in patients with malignant neoplasms
by: N. A. Romanenko, et al.
Published: (2020-10-01)

Post-transplant indolent T cell lymphoproliferative disorder in living donor liver transplantation: a case report
by: Ryoichi Goto, et al.
Published: (2020-06-01)

Incidence, characteristics, and treatments of peripheral neuropathy in multiple myeloma patients receiving bortezomib (velcade)
by: S. S. Bessmeltsev, et al.
Published: (2022-11-01)

CLINICAL MANIFESTATIONS OF VASCULITIS AT THE ONSET OF MULTIPLE MYELOMA
by: V I Vasil'ev, et al.
Published: (2010-02-01)

Thrombodynamics test efficacy in predicting thromboembolic complications in patients with lymphoproliferative disorders
by: S. V. Ignatyev, et al.
Published: (2024-09-01)

Clinical and biochemical features of some intravenous iron complexes
by: S. Yu. Abashin, et al.
Published: (2014-07-01)

Efficiency of lenalidomide, bortezomib and prednisone (RVP) in patients with newly diagnosed multiple myeloma
by: K. A. Belousov, et al.
Published: (2019-04-01)

A response of rituximab plus lenalidomide therapy in patients with post-transplant lymphoproliferative disease and methotrexate-related lymphoproliferative disorder in the central nervous system: a case report
by: Hanguo Guo, et al.
Published: (2025-05-01)

Efficacy of IsaPomDex triplet therapy in double refractory multiple myeloma patients in real clinical practice in Russia
by: M. V. Solovev, et al.
Published: (2024-12-01)

Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions
by: G. R. Hachatryan, et al.
Published: (2019-01-01)

PHARMACOECONOMIC ANALYSIS OF THE USE OF RIBOMUSTIN® IN THERAPY OF THE FIRST LINE OF A MULTIPLE MYELOMA FOR PATIENTS MORE SENIOR 65 YEARS OLD
by: A. S. Kolbin, et al.
Published: (2015-03-01)